Related Experiment Video
Updated: Aug 28, 2025

Measuring Volatile and Non-volatile Antifungal Activity of Biocontrol Products
Published on: December 5, 2020
Network Analysis Guided Designing of Multi-Targeted Anti-Fungal Agents: Synthesis and Biological Evaluation
Manmeet Singh1, Himanshu Verma1, Priyanka Bhandu1
1Molecular Modeling Lab (MML), Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, Punjab, 147002, India.
Abstract:
During the ongoing pandemic, there have been increasing reports of invasive fungal disease (IFD), particularly among immunocompromised populations. Candida albicans is one of the most common clinical pathogenic microorganisms which have become a serious health threat to population either infected with Covid-19 or on treatment with immunosuppressant's/broad-range antibiotics. Currently, benzothiazole is a well explored scaffold for anti-fungal activity, especially mercapto substituted benzothiazoles. It is reported that exploring the 2nd position of benzothiazoles yield improved anti-fungal molecules. Therefore, in the current study, lead optimization approach using bioisosteric replacement protocol was followed to improve the anti-fungal activity of an already reported benzothiazole derivative, N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide. To rationally identify the putative anti-candida targets of this derivative, network analysis was carried out. Complexes of designed compounds and identified putative targets were further analyzed for the docking interactions and their consequent retention after the completion of exhaustive MD simulations. Top seven designed compounds were synthesized and evaluated for in-vitro anti-fungal property against Candida, which indicated that compounds 1.2c and 1.2f possess improved and comparable anti-fungal activity to N-(1,3-benzothiazole-2-yl)-2-(pyridine-3-ylformohydrazido) acetamide and Nystatin, respectively.
Insights
New benzothiazole derivatives show promise in combating invasive fungal disease (IFD), particularly Candida albicans infections in immunocompromised patients. Compounds 1.2c and 1.2f demonstrated enhanced anti-fungal properties in vitro.
Area of Science:
- Medicinal Chemistry
- Mycology
- Computational Chemistry
Background:
- Invasive fungal disease (IFD) is a growing concern, especially in immunocompromised individuals during the pandemic.
- Candida albicans presents a significant health threat, often complicating COVID-19 treatments and immunosuppressive therapies.
- Benzothiazole scaffolds, particularly mercapto-substituted ones, are recognized for their antifungal potential, with modifications at the 2nd position showing promise.
Purpose of the Study:
- To optimize an existing benzothiazole derivative for improved anti-Candida albicans activity using a lead optimization strategy.
- To identify potential molecular targets for the designed compounds through network analysis.
- To synthesize and evaluate novel benzothiazole derivatives for their in vitro antifungal efficacy.
Main Methods:
- Lead optimization employing bioisosteric replacement on a known benzothiazole derivative.
- Network analysis to predict anti-Candida targets.
- Molecular docking and molecular dynamics (MD) simulations to assess compound-target interactions.
- In vitro antifungal assays against Candida species.
Main Results:
- Seven novel benzothiazole derivatives were synthesized.
- Compounds 1.2c and 1.2f exhibited enhanced and comparable in vitro antifungal activity against Candida, respectively.
- Network analysis and molecular simulations provided insights into potential drug targets and binding interactions.
Conclusions:
- The study successfully optimized a benzothiazole derivative, yielding compounds with significant in vitro antifungal activity against Candida.
- The findings suggest that these novel derivatives are potential candidates for further development as antifungal agents.
- The integration of computational methods aided in the rational design and target identification process.
More Related Videos
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Antimicrobial Effectiveness

